Inomagen Therapeutics reported raising $200,000 in an initial SEC Form D filing, from an offering of $6.63 Million
PRIVATEApr 12, 2024
Round Type
Pre-Seed
ChicagoBiotechnologyWho to call at Inomagen Therapeutics, and when
A new round usually means Inomagen Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Inomagen Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inomagen Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inomagen Therapeutics. With Fundz connected, it knows.
Watch Fundz in
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Inomagen Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
1 contact
Inomagen Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.